Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07426172 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Role of Elevated Lactate Levels on Lipid and Carbohydrate Metabolism.

Study acronym: LACTMET
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
The purpose of this study is to investigate whether the elevated circulating lactate levels of individuals with metabolic syndrome are responsible for their reduced lipolysis and glucose tolerance. The investigators will conduct an intervention study in which blood lactate levels will be elevated via intravenous infusion of sodium lactate. State of the art metabolic assessment using stable isotopes and indirect calorimetry will be used to study alterations in fat and carbohydrate metabolism.
Trial Details
NCT Number NCT07426172
Lead Sponsor Ricardo Mora
Collaborators: University of Castilla-La Mancha
Conditions
(from sponsor)		 Hyperlactatemia, Metabolic Syndrome (MetS), Lipolysis, Exercise
Related terms Hyperlactatemia, Metabolic Syndrome, Motor Activity
Enrollment 24 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov